Carmel Diagnostics developed and validated a system for embryo selection in IVF process that substantially improves the success rate, We won Phase-1 and 2 of SME Instrument (Horizon2020) and built new generation of our device. The system is a platform and may have many additional applications in women's health and other pathologies. Fertissimo TCL Analyzer is an innovative, non-invasive embryo selection system for the IVF market, offering up to 25% increase in successful IVF pregnancies. Effective embryo viability assessment significantly improves success rate and reduces the risk of multiple births. Successful clinical trials were performed in Israel and in Europe (Spain). Accurate, scientifically based, NON-INVASIVE solution to the embryo selection application - the "holy grail" of the IVF process.- Low cost device, minimal initial investment for the users- Very friendly, easy-to-use system- Optional oocyte quality testing- Examining the patient's probability for pregnancy - Testing cryopreserved - thawed embryos